Eli Lilly and Alexandria Real Estate Equities are among the investors in a round that took the protein drug developer’s total funding to over $150m.

Myeg returned for augmented reality technology developer HiScene's $41.6m series C-plus round while celiac disease drug developer Calypso Biotech hiked a corporate-backed round to over $33m.

Illumina’s corporate venturing unit took part in a round that brought the proteomic platform developer’s overall funding to $110m.

Ericsson Ventures has participated in a series B round for cybersecurity software provider TrueFort, reportedly increasing its total funding to almost $48m.

The Coinbase Ventures-backed fraud prevention tool developer has secured the fresh round that boosted its total funding to over $48m.

Stratasys spinoff Evolve Additive Solutions secured $30m from 3D Ventures while CollegeDekho - spun off by GirnarSoft - raised $26.5m.

The online lender, which is backed by Telefónica’s Wayra unit, has completed a $75m close, tripling its valuation to the nine-digit dollar range.

SR One Capital Management has led the RNA targeting drug developer’s latest round, participating alongside investors including Lilly Asia Ventures.

Gradient Ventures has returned to back the software debugging technology provider’s series B round, which took its overall funding to $41m.

The semiconductor wafer maker intends to ramp up its production capacity with funding from investors including Yangtze Optical FC.